Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: A Children's Oncology Group phase 1 consortium study

Yael P. Mossé, Megan S. Lim, Stephan D. Voss, Keith Wilner, Katherine Ruffner, Julie Laliberte, Delphine Rolland, Frank M. Balis, John M. Maris, Brenda J. Weigel, Ashish M. Ingle, Charlotte Ahern, Peter C. Adamson, Susan M. Blaney

Research output: Contribution to journal › Article › peer-review

581 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: A Children's Oncology Group phase 1 consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences